RADIOACTIVE IODINE IN THE TREATMENT OF HYPERTHYROIDISM (EXPERIENCE AT THE TORONTO GENERAL HOSPITAL, 1950-58). PART II. POST-I$sup 131$ THYROIDITIS

Journal Article · Sun Jan 01 04:00:00 EST 1961 · Canadian Medical Association Journal (Canada)

OSTI ID:4098128

Volpe, R; Schatz, D L; Scott, A; Peller, J A; Vale, J M; Ezrin, C; Johnston, M W

Clinical findings are reported on a group of hyperthyroid patients treated with I/sup 131/. In virtually all cases of diffuse goiters, as well as postthyroidectomy recurrent goiters, the goiter regressed to a normal or subnormal size. In the toxic nodular group there was invariably a reduction in size of the goiter, which occasionally was complete. More often, nodules persisted although the glands were much smaller in size. Data are included on the incidence of transient hypothyroidism after I/sup 131/ therapy, the number of doses of I/sup 13/< s1>s in the entire group and in those becoming hypothyroid, and the causes of death during a two-year period following I/sup 131/ therapy. (C.H.)

• Research Organization: Univ. of Toronto; and Toronto General Hospital
• NSA Number: NSA-15-008447
• OSTI ID: 4098128
• Journal Information: Canadian Medical Association Journal (Canada), Journal Name: Canadian Medical Association Journal (Canada) Vol. Vol: 84: No. 1; ISSN CMAJA
• Country of Publication: Country unknown/Code not available
• Language: English

Related Subjects

BIOLOGY AND MEDICINE
DISEASES
GLANDS
IODINE 131
MAN
MEDICINE
THYROID